Paid Advertisement
Featuring Dr Norman Lepor, MD
Cardiologist
Cedars-Sinai
Beverly Hills, CA
Sunday, 11:15 am | Learning Studio 4
How are you approaching LDL-C management in patients with hypercholesterolemia and ASCVD? Join us for a closer look at new guideline recommendations and how a nonstatin LDL-C–lowering therapy may help get your appropriate patients to goal.
Program Features
- 2026 ACC/AHA Dyslipidemia Guideline position on LDL-C targets and adherence
- Efficacy and safety data from pivotal and long-term trials
- Real-world adherence and persistence data
- Acquisition pathways, coverage, and affordability
For nonstatin LDL-C–lowering resources, visit out Digital Education Library at cvperspectives.com.
This event is not part of the official Scientific Sessions 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.